The American Heart Association (AHA) will host Scientific Sessions 2025 (AHA25) from Nov. 7 – 10 at the New Orleans Ernest N.

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

The scientific sessions began with a CME-cum-workshop on critical care and disaster management, where experts underscored the ...

In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...

The American Heart Association’s (AHA) Scientific Sessions 2025 begin today in New Orleans, Louisiana, and the Cardiology Advisor team is excited to bring to our readers the latest research and ...

For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and at ...

Presentations reveal new insights on heart health, including inflammation, MINOCA, kidney function, and maternal outcomes.

Anumana will present groundbreaking clinical studies showing how AI-enhanced ECGs can uncover early signs of heart disease ...

New research has raised concerns about the long-term use of melatonin supplements, which are widely available for purchase in ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for ...

MONTREAL, Nov. 5, 2025 /CNW/ – Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing a series of novel ...